Ascendis Pharma A/S ADR | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
5,415.40
12,810.80
36,507.90
75,780.00
139,747.60
153,481.90
Depreciation, Depletion & Amortization
537.70
668.50
618.80
748.90
827.90
1,038.20
Other Funds
1,727.20
2,447.30
7,144.80
3,962.40
25,992.10
13,320.60
Funds from Operations
7,680.30
14,589.60
43,033.90
71,068.70
112,927.60
165,764.30
Changes in Working Capital
697.00
9,821.00
5,166.50
4,498.90
5,662.20
2,012.70
Net Operating Cash Flow
8,377.30
24,410.60
48,200.40
66,569.80
107,265.40
163,751.70
Capital Expenditures
1,586.50
537.20
1,152.20
743.40
1,061.40
Net Investing Cash Flow
1,586.50
537.20
1,152.20
743.40
1,061.40
Issuance/Reduction of Debt, Net
292.10
-
-
-
-
Net Financing Cash Flow
292.10
63,546.00
117,259.50
129,936.10
140,677.10
Net Change in Cash
6,498.70
40,770.90
77,050.10
67,124.00
16,943.80
Free Cash Flow
6,790.80
24,947.80
49,352.50
67,313.20
108,326.80
Change in Capital Stock
-
63,546.00
117,259.50
129,936.10
140,677.10
Exchange Rate Effect
-
2,172.70
9,143.10
4,501.10
15,406.50
About Ascendis Pharma A/S
View Profile
